Saeed Sadeghi, MD, discusses valuable feedback he heard from oncologists on the use of luspatercept-aamt in patients with low-risk myelodysplastic syndrome.
Akriti Jain, MD, discusses her presentation from the 2024 American Society of Hematology Meeting and Exposition.
Significant advancements in lung cancer treatment were seen throughout 2024, from new drug approvals to promising clinical ...